Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)

Abstract Immunotherapy is now widely established as a potent and effective treatment option across several types of cancer. However, there is increasing recognition that not all patients respond to immunotherapy, focusing attention on the immune contexture of the tumor microenvironment (TME), driver...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Paolo A. Ascierto, Carlo Bifulco, Luigi Buonaguro, Leisha A. Emens, Robert L. Ferris, Bernard A. Fox, Greg M. Delgoffe, Jérôme Galon, Cesare Gridelli, Marco Merlano, Paul Nathan, Kunle Odunsi, Hideho Okada, Chrystal M. Paulos, Sandro Pignata, Kurt A. Schalper, Stefani Spranger, Giampaolo Tortora, Hassane Zarour, Lisa H. Butterfield, Igor Puzanov
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 2019-11-01
Serie:	Journal for ImmunoTherapy of Cancer
Soggetti:	Immunotherapy Checkpoint inhibitors Combination therapy Biomarkers Tumor microenvironment
Accesso online:	http://link.springer.com/article/10.1186/s40425-019-0798-3
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!